Literature DB >> 22684345

Transvaginal resection of a rectal gastrointestinal stromal tumor.

Masayasu Hara1, Satoru Takayama, Atsushi Arakawa, Mikinori Sato, Takaya Nagasaki, Hiromitsu Takeyama.   

Abstract

We herein report a case in which a rectal gastrointestinal stromal tumor (GIST) was resected transvaginally. The patient, a 45-year-old female, had a rectal GIST on the anterior wall of the lower rectum. The tumor was within 6 cm of the anal verge, a location which would normally require performing an ultra-low anterior resection using the Double Staple Technique, and a diverting stoma. To minimize the invasiveness of treatment and to reduce the postoperative morbidity, a transvaginal resection was performed. Under general anesthesia, the posterior vaginal mucosa was incised vertically. The tumor was then excised en bloc with the overlying rectovaginal septum and rectal mesenchymal tissue. The defect was repaired primarily, and a diverting stoma was not required. The procedure was uncomplicated, and the patient was discharged home with an intact anal sphincter function and no abdominal incisions. In female patients, transvaginal resection of low anterior rectal lesions may provide a minimally invasive alternative to the traditional ultra-low anterior resection.

Entities:  

Mesh:

Year:  2012        PMID: 22684345     DOI: 10.1007/s00595-012-0215-8

Source DB:  PubMed          Journal:  Surg Today        ISSN: 0941-1291            Impact factor:   2.549


  14 in total

Review 1.  Current status and prerequisites for natural orifice translumenal endoscopic surgery (NOTES).

Authors:  Morimasa Tomikawa; Hao Xu; Makoto Hashizume
Journal:  Surg Today       Date:  2010-09-25       Impact factor: 2.549

2.  Two hundred gastrointestinal stromal tumors: recurrence patterns and prognostic factors for survival.

Authors:  R P DeMatteo; J J Lewis; D Leung; S S Mudan; J M Woodruff; M F Brennan
Journal:  Ann Surg       Date:  2000-01       Impact factor: 12.969

3.  Transvaginal excision of a large rectal stromal tumor: an alternative.

Authors:  Minia Hellan; Vijay K Maker
Journal:  Am J Surg       Date:  2006-01       Impact factor: 2.565

4.  Gastrointestinal stromal tumors, intramural leiomyomas, and leiomyosarcomas in the rectum and anus: a clinicopathologic, immunohistochemical, and molecular genetic study of 144 cases.

Authors:  M Miettinen; M Furlong; M Sarlomo-Rikala; A Burke; L H Sobin; J Lasota
Journal:  Am J Surg Pathol       Date:  2001-09       Impact factor: 6.394

Review 5.  Gastrointestinal stromal tumors: current diagnosis, biologic behavior, and management.

Authors:  I Pidhorecky; R T Cheney; W G Kraybill; J F Gibbs
Journal:  Ann Surg Oncol       Date:  2000-10       Impact factor: 5.344

Review 6.  Recent advances in cell biology, diagnosis, and therapy of gastrointestinal stromal tumor (GIST).

Authors:  Roberto Logroño; Dennie V Jones; Sohaib Faruqi; Manoop S Bhutani
Journal:  Cancer Biol Ther       Date:  2004-03-10       Impact factor: 4.742

7.  Clinical management of gastrointestinal stromal tumors: before and after STI-571.

Authors:  Ronald P Dematteo; Michael C Heinrich; Wa'el M El-Rifai; George Demetri
Journal:  Hum Pathol       Date:  2002-05       Impact factor: 3.466

Review 8.  Diagnosis of gastrointestinal stromal tumors: A consensus approach.

Authors:  Christopher D M Fletcher; Jules J Berman; Christopher Corless; Fred Gorstein; Jerzy Lasota; B Jack Longley; Markku Miettinen; Timothy J O'Leary; Helen Remotti; Brian P Rubin; Barry Shmookler; Leslie H Sobin; Sharon W Weiss
Journal:  Hum Pathol       Date:  2002-05       Impact factor: 3.466

Review 9.  Pathology and diagnostic criteria of gastrointestinal stromal tumors (GISTs): a review.

Authors:  Markku Miettinen; Mourad Majidi; Jerzy Lasota
Journal:  Eur J Cancer       Date:  2002-09       Impact factor: 9.162

10.  Gastrointestinal stromal tumor of the anal canal: an unusual presentation.

Authors:  Giuseppe R Nigri; Mario Dente; Stefano Valabrega; Paolo Aurello; Francesco D'Angelo; Giuseppe Montrone; Giorgio Ercolani; Giovanni Ramacciato
Journal:  World J Surg Oncol       Date:  2007-02-16       Impact factor: 2.754

View more
  7 in total

1.  Successful Treatment Toward Gastrointestinal Stromal Tumors with Aggressive Behavior.

Authors:  Landolsi Sana; Mannai Saber
Journal:  J Gastrointest Cancer       Date:  2015-09

2.  Transvaginal resection of a rectal leiomyoma: A case report.

Authors:  Nobuhisa Matsuhashi; Takao Takahashi; Kengo Ichikawa; Toshiyuki Tanahashi; Yoshiyuki Sasaki; Yoshihiro Tanaka; Naoki Okumura; Kazuya Yamaguchi; Shinji Osada; Kazuhiro Yoshida
Journal:  Oncol Lett       Date:  2015-10-20       Impact factor: 2.967

3.  Rectal Gastrointestinal Stromal Tumor (GIST) in the Era of Imatinib: Organ Preservation and Improved Oncologic Outcome.

Authors:  Michael J Cavnar; Lin Wang; Vinod P Balachandran; Cristina R Antonescu; William D Tap; Mary Keohan; Sam Singer; Larissa Temple; Garrett M Nash; Martin R Weiser; Jose G Guillem; Julio Garcia Aguilar; Ronald P DeMatteo; Philip B Paty
Journal:  Ann Surg Oncol       Date:  2017-10-20       Impact factor: 5.344

4.  Transsacral excision with pre-operative imatinib mesylate treatment and approach for gastrointestinal stromal tumors in the rectum: A report of two cases.

Authors:  Li-Feng Sun; Jin-Jie He; Shao-Jun Yu; Jing-Hong Xu; Jian-Wei Wang; Jun Li; Yong-Mao Song; Ke-Feng Ding; Shu Zheng
Journal:  Oncol Lett       Date:  2014-08-01       Impact factor: 2.967

Review 5.  Transvaginal excision of rectal stromal tumors: case reports and a literature review.

Authors:  Wang Shizhuo; Ni Sha; Chen Xueting; Wang He; Luan Nannan; Ma Xiaoxin
Journal:  World J Surg Oncol       Date:  2019-10-06       Impact factor: 2.754

6.  Surgically Enucleated Gastrointestinal Tumor of the Rectovaginal Septum.

Authors:  Brian H Le; Jasmine Nguyen; Anna Bossert; Tonie Crandall; Bernice Robinson-Bennett
Journal:  Cureus       Date:  2019-06-27

Review 7.  Recent Advancements in the Treatment of Rectal Gastrointestinal Stromal Tumor: In Era of Imatinib.

Authors:  Hui Qu; ZhaoHui Xu; YanYing Ren; ZeZhong Gong; Ri Hyok Ju; Fan Zhang; HaoNan Kang; Yang Xu; Xin Chen
Journal:  Cancer Manag Res       Date:  2022-03-16       Impact factor: 3.989

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.